A Dose-finding Trial of ETC-1002(Bempedoic Acid) in Patients With Hypercholesterolemia

NCT04784442 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

188

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypercholesterolemia

Interventions

DRUG: 180mg of ETC-1002(bempedoic acid)
DRUG: 120mg of ETC-1002(bempedoic acid)
DRUG: 60mg of ETC-1002(bempedoic acid)
DRUG: Placebo

Sponsor

Otsuka Pharmaceutical Co., Ltd.